Related Experiment Videos
Radiologic recommendation for breast biopsy on screening mammography reports.
G W Geelhoed1, H M Barr, D J Curtis
1Department of Surgery, George Washington University Medical Center, Washington, DC.
The American Surgeon
|July 1, 1991
Summary
Radiologists can accurately re-evaluate mammograms, reducing unnecessary breast biopsies. This approach improves diagnostic confidence and patient care for suspicious, nonpalpable lesions.
Area of Science:
- Radiology
- Breast Imaging
- Diagnostic Accuracy
Background:
- Screening mammography frequently leads to recommendations for breast biopsy of nonpalpable lesions.
- This conservative approach can cause patient anxiety and surgical challenges.
- Accurate differentiation between benign and malignant nonpalpable breast lesions is crucial.
Purpose of the Study:
- To evaluate the accuracy of mammographic interpretation in identifying nonpalpable breast lesions.
- To assess the potential for reducing unnecessary biopsies through expert re-evaluation.
- To determine the diagnostic performance of mammographers in characterizing suspicious findings.
Main Methods:
- A series of 84 patients with mammographically detected, nonpalpable suspicious lesions were reviewed.
- Needle localization was performed on 69 patients; 15 had revised mammographic interpretations without biopsy.
- Diagnostic performance metrics (specificity and sensitivity) were calculated based on prereading by the mammographer.
Main Results:
- A 21% cancellation rate of recommended biopsies was observed after re-evaluation.
- Cancer was found in 28% of patients undergoing needle localization, higher than the national average.
- The mammographer's prereading demonstrated 94% specificity and 96% sensitivity for cancer detection.
Conclusions:
- Expert mammographic re-evaluation can significantly reduce unnecessary biopsies for nonpalpable breast lesions.
- The diagnostic accuracy of experienced mammographers is high, supporting this approach.
- This strategy enhances diagnostic precision and potentially improves patient outcomes in breast cancer screening.